PANE, FABRIZIO
 Distribuzione geografica
Continente #
EU - Europa 927
NA - Nord America 827
AS - Asia 271
AF - Africa 53
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2082
Nazione #
US - Stati Uniti d'America 821
GB - Regno Unito 434
SE - Svezia 163
VN - Vietnam 107
IT - Italia 92
CN - Cina 89
DE - Germania 79
IE - Irlanda 51
IN - India 45
FR - Francia 33
RU - Federazione Russa 27
TG - Togo 22
JO - Giordania 21
EE - Estonia 19
ZA - Sudafrica 19
UA - Ucraina 10
CA - Canada 6
CI - Costa d'Avorio 6
GR - Grecia 5
IR - Iran 5
NG - Nigeria 5
NL - Olanda 3
PL - Polonia 3
AT - Austria 2
AU - Australia 2
FI - Finlandia 2
MY - Malesia 2
BE - Belgio 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
KR - Corea 1
LB - Libano 1
MA - Marocco 1
NO - Norvegia 1
RO - Romania 1
Totale 2082
Città #
Southend 422
Chandler 173
Fairfield 100
Dong Ket 86
Ashburn 56
Houston 54
Dublin 51
Woodbridge 51
Seattle 49
Princeton 45
Wilmington 37
Ann Arbor 28
Cambridge 27
Lomé 22
Amman 21
Westminster 20
Padova 19
Nanjing 18
Medford 17
Beijing 12
Bologna 11
Shenyang 11
Milan 9
Berlin 8
Hebei 8
Jinan 8
Saint Petersburg 8
San Diego 8
Abidjan 6
Changsha 6
Torino 6
Abeokuta 5
Redwood City 5
Toronto 5
Bremen 4
Nanchang 4
Rome 4
Tianjin 4
Des Moines 3
Hangzhou 3
Jiaxing 3
Ningbo 3
Norwalk 3
Olalla 3
Andover 2
Boardman 2
Castelnuovo Rangone 2
Chicago 2
Falls Church 2
Fremont 2
Grafing 2
Groningen 2
Helsinki 2
Henderson 2
Kunming 2
Mogliano Veneto 2
Pugliano 2
Redmond 2
Serra 2
Zanjan 2
Baotou 1
Brisbane 1
Brussels 1
Buffalo 1
Clayton 1
Costa Mesa 1
Den Haag 1
Dong Nai 1
Fuzhou 1
Haikou 1
Jacksonville 1
Johor Bahru 1
Kiev 1
Kuala Lumpur 1
Kuban 1
La Canada Flintridge 1
Langfang 1
Lausanne 1
Leawood 1
Limbiate 1
Lincoln 1
London 1
Ludwigshafen 1
Melbourne 1
Modena 1
Moscow 1
Napoli 1
Novokuznetsk 1
Nürnberg 1
Paris 1
Parma 1
Peterborough 1
Plauen 1
Ravenna 1
Roubaix 1
Sacramento 1
San Mateo 1
Sassari 1
Suceava 1
Taizhou 1
Totale 1518
Nome #
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia 313
BCR-ABL1 transcript detection in patients with Philadelphia-positive Acute Lymphoblastic Leukemia (ALL) using a new and high sensitive nanofluidic method 133
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 131
The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors 103
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) 101
The 'Next-in-Cml' Study: A Prospective Multicenter Study of Deep Sequencing of the BCR-ABL1 Kinase Domain in Philadelphia Chromosome-Positive Patients with Non-Optimal Responses to Tyrosine Kinase Inhibitor Therapy 96
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia 94
An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease 92
null 91
Evaluation of Cepheid Xpert® BCR-ABL Monitor Assay in Three Italian Reference Centers for Monitoring of BCR-ABL Transcript Levels in CML Patients 90
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 90
One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study 87
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients. 81
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report 78
High-resolution molecular allelokaryotyping identifies novel genomic alterations in acute promyelocytic leukemia (APL) 77
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients 75
Molecular Characterization of PAX5 alterations in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) 67
Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients 67
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia 63
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors 60
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation 55
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 48
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 47
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 4
Totale 2143
Categoria #
all - tutte 3349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201856 0000 00 00 603911
2018/2019150 72053 621 32 18221033
2019/2020442 8021429 3426 4949 56363721
2020/2021481 60271116 2627 3737 413021148
2021/2022503 34214039 5327 826 21519291
2022/2023490 48931977 3747 2129 119000
Totale 2143